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Transplantation of Neural Differentiated Human Mesenchymal 
Stem Cells into the Cochlea of an Auditory-neuropathy Guinea 
Pig Model
The aim of this study was to determine the effects of transplanted neural differentiated 
human mesenchymal stem cells (hMSCs) in a guinea pig model of auditory neuropathy. In 
this study, hMSCs were pretreated with a neural-induction protocol and transplanted into 
the scala tympani of the guinea pig cochlea 7 days after ouabain injury. A control model 
was made by injection of Hanks balanced salt solution alone into the scala tympani of the 
guinea pig cochlea 7 days after ouabain injury. We established the auditory neuropathy 
guinea pig model using 1 mM ouabain application to the round window niche. After 
application of ouabain to the round window niche, degeneration of most spiral ganglion 
neurons (SGNs) without the loss of hair cells within the organ of Corti and increasing the 
auditory brain responses (ABR) threshold were found. After transplantation of neural 
differentiated hMSCs, the number of SGNs was increased, and some of the SGNs expressed 
immunoreactivity with human nuclear antibody under confocal laser scanning microscopy. 
ABR results showed mild hearing recovery after transplantation. Based on an auditory 
neuropathy animal model, these findings suggest that it may be possible to replace 
degenerated SGNs by grafting stem cells into the scala tympani.
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ORIGINAL ARTICLE
Cell Therapy & Organ Transplantation
INTRODUCTION
The loss of auditory afferent neurons, the spiral ganglion neu-
rons (SGNs), can lead to sensorineural hearing loss (SNHL). 
This can occur from primary neuronal loss involving degenera-
tion of neurons in the absence of hair cell degeneration (1) or 
secondary to the loss of hair cells that normally supply trophic 
support to SGNs (2). Auditory neuropathy (AN) results when 
degeneration of SGNs occurs in the presence of functional hair 
cells (3). A recent study demonstrated that application of oua-
bain, a well-known cardiac glycoside, to the round window re-
sulted in a loss of SGNs, which serves as a model of AN (4, 5).
  Currently, the use of a cochlear implant is the only method to 
treat the deaf resulting from the loss of hair cells or the loss of 
SGNs. However, survival of SGNs is a significant issue for ob-
taining the hearing benefits provided by cochlear implants. 
Many researchers seek methods for protection of SGNs (6-8) 
because SGNs do not regenerate to any clinically significant ex-
tent after neural degeneration. 
  Stem cell replacement therapy raises the hope for hearing 
loss (9, 12). Among the various types of stem cells, bone mar-
row-derived mesenchymal stem cells (MSCs) are one of the 
most promising stem cell sources for cell replacement therapy 
because they can differentiate into neurons (13) and can be 
used by the patient’s own bone marrow (14). Moreover, bone 
marrow transplantation has been shown to be a safe procedure 
for decades without any incidents of tumor formation in host 
tissues after transplantation. Primary MSCs have been proven 
to survive in the inner ear and to replace the lost SGNs (15, 16). 
However, it remains unclear whether neural differentiated MSCs 
can serve as better sources for cell replacement therapy in in-
jured cochleae. Previously, it has been reported that neuronal 
differentiation of MSCs could be induced by application of ba-
sic fibroblast growth factor (bFGF), forskolin, and ciliary neuro-
trophic factor (14, 17, 18). In this study we have shown that neu-
ral differentiated human MSCs have the potential not only to 
replace the lost SGNs, but also to promote hearing recovery in 
the AN guinea pig model.Cho Y-B, et al.  •  Transplantation of MSCs into the Cochlea of an Auditory Neuropathy 
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MATERIALS AND METHODS
Preparation of human MSCs and in vitro neural 
differentiation
Previously, we have reported neural differentiation of human 
MSCs (19, 20). Briefly, human bone marrow was obtained from 
the mastoid process during mastoidectomy for ear surgery. In-
formed consent was obtained from all donors according to the 
guidelines of the Ethics Committee of the Chonnam National 
University Hospital. Human MSCs were isolated from the bone 
marrow and grown as adherent cultures in Dulbecco’s Modi-
fied Eagle’s Medium (DMEM; Hyclone, Logan, UT, USA) sup-
plemented with 10% fetal bovine serum (FBS; Hyclone) and 1% 
penicillin-streptomycin (Hyclone). After 4 weeks, MSCs were 
grown to approximately 80% confluence in a 37°C humidified 
incubator with a 5% CO2 and 95% air environment. This stage 
was termed passage 0 (P0). The human MSCs used in the pres-
ent study were obtained from passages 3-6. 
  To induce neural differentiation, MSCs were grown in DMEM 
containing 1% FBS and supplementary 100 ng/mL of bFGF (In-
vitrogen Corporation, Carlsbad, CA, USA) for 7 days. The cells 
were then incubated in the presence of 10 μM forskolin (Sigma 
Chemical Co., St. Louis, MO, USA). Over the next 7 days, the cells 
were characterized and used for transplantation into the AN 
guinea pig model. 
AN animal model and human MSC transplantation
Twenty-four female guinea pigs, weighing 250-350 g, were used 
in the present study. Animal care complied with institutional 
guidelines. All surgical procedures were performed under asep-
tic conditions. The guinea pigs were anesthetized with pentobar-
bital sodium (40 mg/kg) by intraperitoneal injection. The mi-
crosurgical techniques were performed under an operating mi-
croscope (Zeiss OPMI
® pico; Carl Zeiss, Goettingen, Germany). 
  To make an AN model, the right post-auricular region of the 
guinea pigs was shaved and sterilized with potadine and 70% 
ethanol following anesthesia (see above). The animal was then 
placed on a heating pad (37°C), and the right bulla was opened 
widely and the round window niche was exposed. A piece of gel-
atin sponge soaked with 1 mM ouabain (Sigma Chemical Co.) 
was placed on the round window membrane. Then, the inci-
sion was closed with sutures. The animals were randomly di-
vided into 2 groups (n = 8 per group), as follows: control group, 
Hanks balanced salt solution (HBSS; Hyclone) without neural-
induced human mesenchymal stem cell (nhMSC) transplanta-
tion into the cochlea; and stem cell group, HBSS with nhMSC 
transplantation into the cochlea.
 
Neural-induced human MSC transplantation 
Transplantation of nhMSCs was performed 7 days after ouabain 
application. Procedures for animal preparation and anesthesia 
were similar to those described above. The right bulla was sur-
gically exposed and opened to visualize the basal cochlea using 
a post-auricular incision. A small hole was made into the scala 
tympani at the basal cochlear turn using a 0.8-mm diamond 
drilling burr. HBSS with nhMSCs (1 × 10
5 cells in 5 μL) or HBSS 
alone was then injected into the right scala tympani through the 
small hole using a Hamilton syringe and microinfusion pump 
at a speed of 2 μL/min (Fig. 1). After injection, the hole was 
plugged with small connective tissue and a fibrin-based adhe-
sive agents (Greenplast
®; Green-Cross, Seoul, Korea), and the 
incision was approximated with sutures.
 
Outcome measurement by histologic analysis 
Histologic evaluation was performed 6 weeks after the transplan-
tation. The animals were sacrificed by administration of a high 
dose of pentobarbital sodium. The cochleae were carefully re-
moved, trimmed, fixed in 5% paraformaldehyde, then decalci-
fied for 2 weeks in 10% EDTA. The fixed, decalcified cochleae 
were embedded in paraffin wax for paraffin section. The paraf-
fin-embedded cochlea was sliced info 5-μm-thick serial paramo-
diolar sections. The sections were mounted on glass slides and 
the morphology was checked via hematoxylin and eosin stain-
ing. We obtained spiral ganglion images with a magnification of 
Fig. 1. Photomicrographs of stem cell transplantation method. (A) Visualization of the round window after opening the bulla. (B, C) Note the tip of a needle of a Hamilton syringe 
is inserted into the most basal turn of the scala tympani, where neural-induced human mesenchymal stem cells (nhMSCs) or Hanks balanced salt solution (HBSS) were injected (C, 
H&E staining, × 40). 
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× 400 using a Nikon camera (Tokyo, Japan). These images were 
then printed on 10 × 7.5 cm photographic paper for neuron 
counting. Quantitative histology values were used to calculate 
the neuron density (neurons per field divided by the partial spi-
ral ganglion cross-sectional area in each turn).
  After blocking in 1% normal goat serum, the sections were 
incubated overnight at 4°C with a primary antibody diluted in 
phosphate-buffered saline (pH 7.4). The primary antibodies 
used in this study were anti-human nuclei (1:200), Math1 (1:200), 
and NF-H (1:300). Then, the sections were incubated with FITC- 
and rhodamine-conjugated secondary antibodies to visualize 
primary antibodies. 4’6-diamidino-2-phenylindole (DAPI) was 
used to label nuclei. All primary and secondary antibodies were 
purchased from Chemicon, except for Math1 (Ambion, Austin, 
TX, USA). Fluorescent images were obtained using a Zeiss 
LSM510 confocal microscope (Carl Zeiss Inc., Jena, Germany). 
The captured images were processed using Zeiss LSM Image 
Browser version 4, 2, 0, 121 (Carl Zeiss Inc.) and Adobe photo-
shop CS.
Auditory Brain Responses (ABR) measurement and 
analysis
ABR recordings were carried out using commercial auditory-
evoked potential equipment (Navigator SE evoked potential 
system; Bio-logic Systems Corp., Mundelein, IL, USA) at vari-
ous intervals (1, 3, and 5 weeks) after the transplantation. The 
animals were placed in a prone position after anesthesia (see 
above). ABRs were elicited using 11.1/sec alternating polarity 
clicks (150-3,000 Hz, stimulation rate 11/sec [reflecting lower 
frequency responses]) and 8 kHz (reflecting middle frequencies) 
alternating polarity tone bursts, a rise and fall time of 5 msec, 
and a plateau of 5 msec shaped with a Blackman window. The 
stimuli were delivered to the ear using an insert earphone. Re-
sponse signals were recorded by three silver needle electrodes. 
The electrodes were placed in the vertex for an active electrode 
and in the bilateral retroauricular region for ground and refer-
ence electrodes. The responses were digitally band-passed fil-
tered (100-3,000 Hz), amplified, and time-averaged (n = 512 to 
1,024) for a post-stimulus time window of 9.98 msec. Stimulus 
intensity from a 90-decibel (dB) sound pressure level (SPL) was 
used, down to threshold in 10 dB, then 5 dB steps around the 
threshold level. The thresholds of ABRs were measured by de-
tecting the presence of wave V. At the threshold intensity, at least 
two sequences of recordings were made to confirm response 
reproducibility.
Statistical analysis
All results were reported as the mean ± standard error of the 
mean. Statistical analysis was performed with an independent 
sample t-test for comparison of two experimental groups using 
SPSS (version 17.0; SPSS, Inc., Chicago, IL, USA). A value of P < 
0.05 was considered to be significant.
Ethics statement
This study protocol and procedures were reviewed and approved 
by the institutional review board (I-2009-03-016) and the insti-
tutional animal care and use committee of the Chonnam Na-
tional University Hospital. 
RESULTS
Effect of ouabain on SGNs 
All experimental animals exhibited normal hearing with click-
evoked ABR thresholds of -10 ± 10 dB prior to application of 
ouabain. Fig. 2 shows the effect of ouabain on SGNs. After 7 days 
of ouabain application, a severe decrease in SGNs was general-
Fig. 2. Ouabain-induced spiral ganglion neuropathy. (A) There is a severe loss of spiral ganglion neurons (SGNs) without a loss of hair cells after 7 days of ouabain application (H 
&E staining, original magnification × 40 and × 200). (B) Also, an increase of the hearing threshold is noted (dB, decibel). V, wave v.
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ly representative for all turns in the right ears. Despite the appar-
ent loss of afferent innervation, hair cells were preserved in all 
turns. Also, the hearing threshold was increased in ABR mea-
surements. 
Transplanted neural differentiated hMSCs survive in the 
spiral ganglion
We explored the localization of nhMSCs after transplantation 
into the AN guinea pig cochlea 6 weeks after nhMSC transplan-
tation. In the control group (Fig. 3A), severe loss of SGNs and 
sensory hair cells from the basal to the apical turns of the cochlea 
was noted. In contrast, in the stem cell group (Fig. 3B) the num-
ber of SGNs and sensory hair cells was increased in all turns of 
the cochlea 6 weeks after stem cell grafting.
  Even without the use of immunosuppressants, there was no 
evidence of acute rejection, which usually occurs within the first 
6 months following transplantation. No significant inflamma-
tion response was observed in the stem cell group.
  We used human-specific anti-nuclei antibodies to specifical-
ly identify human cells in the transplanted guinea pig inner ear 
cochlea. Transplanted human nuclei-positive cells located in 
the spiral ganglion expressed NF-H, a neural cell marker, sug-
gesting differentiation into neuronal cells (Fig. 4). 
  Based on quantitative histologic analysis, the average num-
ber of neurons in each turn of the spiral ganglion was signifi-
cantly greater in the stem cell group than in the control group 
(Fig. 5). In the control group, the average number of neurons in 
the basal, 2nd, 3rd, and 4th turns was 9.00 ± 1.27/1,000 μm
2, 9.50 
Fig. 3. Histologic findings of 
cochlea after stem cell tran- 
splantation. (A) Severe loss 
of SGNs and sensory hair 
cells from the basal to the 
apical turn of the cochlea is 
noted 6 weeks after HBSS 
injection (control group). (B) 
Numerous SGNs and sensory 
hair cells are observed in all 
turns of the cochlea 6 weeks 
after stem cell grafting (stem 
cell group). (H&E staining,   
× 40 and × 200).
A B
Fig. 4. Confocal microscope image after immu- 
nostaining for anti-human nuclei and NF-H. (A) 
Numerous neurons are observed in the spiral 
ganglion (black arrow) after 6 weeks of stem 
cell transplantation (H&E staining, × 40). (B) 
the expression of anti-human nuclei (red) and 
NF-H (green) co-localizes with that of DAPI 
(blue)-positive cells in the spiral ganglion. Grafted 
stem cells (white arrow) are located in the spiral 
ganglion (× 200).
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Fig. 5. Average neuron counts in each turn of the spiral ganglion 6 weeks after trans-
plantation. Average number of neurons in each turn of the spiral ganglion is significantly 
greater in the stem cell group than in the control group (*P < 0.05).
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Fig. 6. Auditory brainstem response (ABR) results after 
nhMSC transplan  tation. Click-evoked ABR waves are 
recorded up to -10 ± 10 dB in normal guinea pigs. Seven 
days after application of 1 mM ouabain to the round win-
dow, an increase of ABR threshold is noted. After recei-
ving a nhMSC transplantation, the auditory neuropathy 
guinea pigs show a significant improvement in hearing 
threshold compared to the control group (*P < 0.05). 
Stem cell  
transplantation
Stem cell  
transplantation
HBSS control
HBSS control
± 2.63/1,000 μm
2, 7.63 ± 1.36/1,000 μm
2, and 11.88 ± 3.10/1,000 
μm
2, respectively. In the stem cell group, the average number of 
neurons in the basal, 2nd, 3rd, and 4th turns was 15.30 ± 1.51/ 
1,000 μm
2, 26.64 ± 1.46/1,000 μm
2, 22.00 ± 1.99/1,000 μm
2, and 
21.44 ± 0.77/1,000 μm
2, respectively. 
Hearing recovery results after nhMSC transplantation 
Although evidence exists that transplanted nhMSCs differenti-
ate to NF-H-positive neuronal cells in the spiral ganglion to re-
place the lost cells in the AN guinea pig model, it is not clear if 
transplanted stem cells can enhance the hearing threshold. To 
evaluate the effect of nhMSC transplantation on hearing recov-
ery in an AN guinea pig, we measured the ABR thresholds be-
fore, and 1, 3, and 5 weeks after the transplantation. The ABR 
was evoked by two types of stimuli (alternative click sound and 
an 8 kHz pure tone burst sound). All experimental animals ex-
hibited normal hearing with click-evoked ABR thresholds of 0 ± 
10 dB prior to AN modeling. Seven days after the application of 
1 mM ouabain on the round window, an increase of hearing 
threshold (63.00 ± 4.90 dB at click-evoked stimuli and 70.00 ± 
5.70 dB at 8 kHz tone burst stimuli) was noted. After receiving a 
transplantation of nhMSCs, the guinea pigs showed a signifi-
cant improvement in hearing threshold compared to the con-
trol group. Five weeks after the transplantation, average ABR 
thresholds for the click and 8 kHz tone burst stimuli were de-
creased to 46.00 ± 6.00 dB and 66.00 ± 2.45 dB, respectively (Fig. 
6). The considerable improvement in hearing function observed 
in the ABR test is consistent with the restoration of SGNs in the 
stem cell group. 
 
DISCUSSION
Recent advance in studies on stem cells have suggested the pos-
sibility of clinical use of stem cell transplantation for ischemic 
brain disease and neurodegenerative disorders (21, 22). Also, 
restoration of SGNs is one of the targets for stem cell therapy in 
the treatment of hearing loss (23). The present study provides 
the scientific basis for a requirement of neural differentiation of 
MSCs for better treatment and presents the novel demonstra-
tion of a therapeutic approach leading to substantial recovery 
of hearing in AN patients’ ears. Some researchers have reported 
that transplantation of undifferentiated MSCs into the inner ear 
repairs injured cochlear fibrocytes in an animal SNHL model 
and increases survival in the spiral ganglion in an AN model 
(15, 16). 
  Various ototoxic treatments (5, 24) and the aging process lead 
to loss of SGNs (25). The application of ouabain to the round 
window membrane is a well-known method which induces the 
death of most SGNs, and thus provides an excellent model for 
AN (4, 5, 16). In this study, we placed a piece of gelatin sponge 
soaked with 1 mM ouabain on the round window membrane. 
One week after ouabain application, there was a selective and 
permanent destruction of SGNs without loss of hair cells and 
an increase of the ABR threshold. 
  In the present study, the number of SGNs was increased at all 
turns of the cochlea after nhMSC transplantation, and the trans-
planted nhMSCs were positively stained for NF-H, a mature neu-
ronal marker, at the damaged spiral ganglion. This result sug-
gests that the nhMSCs differentiate into neurons and replace 
the lost or damaged neural cells in the spiral ganglion. This find-
ing suggests that the migration and differentiation of grafted 
stem cells are influenced by the cues or signals in the microen-
vironment of the damaged tissue. It is known that damaged cells 
and tissues of the host brain are capable of releasing molecules 
that stimulate the production of neurotrophic factors in trans-
planted MSCs (26).
   The ultimate goal of stem cell therapy in AN patients is not 
only restoration of missing SGNs, but also to increase hearing Cho Y-B, et al.  •  Transplantation of MSCs into the Cochlea of an Auditory Neuropathy 
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function. In this study, the decreased average ABR thresholds 
for click and 8 kHz tone burst stimuli indicated that nhMSC 
transplantation is an effective treatment method for AN. Be-
cause the presence of some SGNs is known to enhance the func-
tion of cochlear implants, the regeneration or protection of SGNs 
via nhMSC transplantation would also improve the therapeutic 
effect of cochlear implantation (27, 28). Thus, our results sug-
gest that the transplantation of nhMSCs at the time of cochlear 
implant surgery could improve hearing recovery. 
  In this study, it is possible that immunologic rejection of trans-
planted cells occurred in this experiment because we used the 
xenotransplantation procedure. Xenotransplantation was per-
formed in this study because we sought the effectiveness of hu-
man MSCs on cochlear repair. Although immunologic rejection 
was expected in this study, there was no evidence of acute rejec-
tion in any of the animals used in our study. Escape from im-
mune surveillance is partly due to the fact that MSCs lack MHC 
class II or inhibit T-cell proliferation (29, 30). Escape from im-
mune surveillance was also caused by some degree of immu-
noprotection of the cochlea provided by the blood-labyrinth 
barrier (16). However, further studies will be required to eluci-
date the long-term immunologic reactions.
  In conclusion, neural differentiated MSCs are able to restore 
damaged SGNs and decrease hearing thresholds in an AN mod-
el. Furthermore, transplantation into the scala tympani is a suit-
able method because numerous grafted nhMSCs were found in 
the spiral ganglion. These findings suggest that it may be possi-
ble to replace degenerated SGNs by grafting stem cells into the 
scala tympani.
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Transplantation of Neural Differentiated Human Mesenchymal Stem Cells into the 
Cochlea of an Auditory-neuropathy Guinea Pig Model
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We investigated the effects of human mesenchymal stem cells (hMSCs) differentiated into neural cells on auditory neuropathy. The 
auditory neuropathy was induced in guinea pigs using 1mM ouabain applied to the round window niche. The differentiated 
hMSCs were transplanted into the scala tympani of the guinea pig cochlea 7 days after the ouabain-induced injury. The application 
of ouabain induced attenuated auditory brainstem response (ABR) and degeneration of spiral ganglion neurons (SGNs) without loss 
of hair cells in the organ of Corti. After transplantation of neural differentiated hMSCs, the number of SGNs was increased and 
the ABR results showed mild hearing recovery. It might be possible to replace degenerated SGNs by grafting stem cells into the 
scala tympani.